Results 141 to 150 of about 60,520 (273)

Olanzapine-Associated Diabetes Mellitus

, 2002
Study Objective. To explore the clinical characteristics of hyperglycemia in patients treated with olanzapine. Design. Retrospective, epidemiologic survey of spontaneously reported adverse events related to olanzapine therapy. Setting.
Elizabeth A. Koller, P. Murali Doraiswamy, Koller, Elizabeth A., Doraiswamy, P. Murali   +3 more
core   +1 more source

Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia

, 2018
Fuyin Yang,1–4 Lan Chen,5 Xinyu Fang,6 Ke Zheng,1 Cheng Zhu,1 Chaoqun Xu,1 Chen Zhang,6 Wei Tang11Wenzhou Kangning Hospital, School of Mental Health, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China; 2Faculty of Arts and Science, New ...
Zheng K, Fang X, Chen L, Xu C, Zhang C, Tang W, Yang F, Zhu C   +7 more
core  

Experiential and Medical Knowledge of Shared Decision‐Making: Exploring Clinician and Service User Perspectives in NHS Community Mental Health Services

Health Expectations, Volume 29, Issue 5, October 2026.
ABSTRACT Background A fundamental barrier to effective recovery outcomes for psychosis, is the lack of involvement of service users (SUs) in decisions made about their care. Despite policy recommendations, implementation of shared decision‐making (SDM) is inconsistent, under‐reported in mental health practice and thus requires further attention.
Karishma Jivraj, Iris Gault, Mary Chambers   +2 more
wiley   +1 more source

Olanzapine induced hyperprolactinemia [PDF]

, 2017
Olanzapine, a second generation antipsychotic is widely used for the treatment of schizophrenia and bipolar disorders. Though olanzapine is an efficacious antipsychotic it has been associated with many adverse effects like weight gain, hyperlipidemia ...
Nayak, Veena, Mallya, Deepak, Devaramane, Virupaksha, Bhandary, Panambur V.   +3 more
core  

Role of Private Practice Dietitians in Working With People With Mental Illness: A Constructivist‐Interpretivist Qualitative Interview Study

Journal of Human Nutrition and Dietetics, Volume 39, Issue 5, October 2026.
ABSTRACT Aims This study aimed to explore dietitians' views, experiences, and perceived barriers and enablers to working with people with mental illness in Australian private and public mental health settings, with a focus on clarifying the contribution of private practice dietitians to mental healthcare.
Michelle Shwu Huey Hsu, Francis Guo, William Morrow, Andrew Watkins, Scott B. Teasdale   +4 more
wiley   +1 more source

Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia

, 2017
Clozapine has been the gold standard for treatment of patients with refractory schizophrenia but is associated with serious safety liabilities. This has prompted the search for therapeutic alternatives for treatment-resistant schizophrenia. The objective
Gagiano CA, Breier A, for the Olanzapine HGCK Study Group, Metcalfe S, Bartko G, Kovacs G, Banki CM, Dossenbach MR, Bitter, István, Janka, Zoltán, Füredi, János, Brook S, Feldman PD   +12 more
core  

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial

JAMA psychiatry, 2017
J. Larsen, Louise Vedtofte, M. L. Jakobsen, H. R. Jespersen, M. I. Jakobsen, C. K. Svensson, K. Koyuncu, O. Schjerning, P. Oturai, A. Kjaer, J. Nielsen, J. Holst, C. Ekstrøm, C. Correll, T. Vilsbøll, A. Fink-Jensen   +15 more
semanticscholar   +1 more source

Olanzapine-Induced Clinical Seizure

, 2009
Atypical antipsychotics are known to be associated with electroencephalogram abnormalities. Olanzapine can lower seizure threshold and induce epileptiform discharges.
Gangadhar, Bangalore N., Behere, Rishikesh V., Anjith, Divakaran, Venkatasubramanian, Ganesan, Rao, Naren P.   +4 more
core   +1 more source

Safety and effectiveness of rapid-acting intramuscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study

, 2018
Hideaki Katagiri,1 Masanori Taketsuna,2 Shinpei Kondo,3 Kenta Kajimoto,4 Etsuko Aoi,5 Yuka Tanji1 1Bio Medicine, 2Statistical Sciences, 3Post Marketing Study Management, 4Scientific Communications, Medicines Development Unit Japan, 5Global Patient ...
Kondo S, Kajimoto K, Katagiri H, Aoi E, Tanji Y, Taketsuna M   +5 more
core  

Physical activity participation in people with severe mental illness: The real challenge

General Psychiatry, Volume 39, Issue 5, October 2026.
Mikel L. Sáez de Asteasu, Simon Rosenbaum, Mikel Izquierdo   +2 more
wiley   +1 more source